These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7490364)

  • 1. Effects of cyclosporine on cytokines and cytokine receptors in psoriasis.
    Prens EP; van Joost T; Hegmans JP; t Hooft-Benne K; Ysselmuiden OE; Benner R
    J Am Acad Dermatol; 1995 Dec; 33(6):947-53. PubMed ID: 7490364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasis.
    de Jong EM; Ferrier CM; de Zwart A; Wauben-Penris PJ; Korstanje C; van de Kerkhof PC
    J Dermatol Sci; 1995 May; 9(3):185-94. PubMed ID: 8664216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A rapidly inhibits epidermal cytokine expression in psoriasis lesions, but not in cytokine-stimulated cultured keratinocytes.
    Elder JT; Hammerberg C; Cooper KD; Kojima T; Nair RP; Ellis CN; Voorhees JJ
    J Invest Dermatol; 1993 Dec; 101(6):761-6. PubMed ID: 8245502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
    Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP
    J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
    Lovato P; Norsgaard H; Tokura Y; Røpke MA
    J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis.
    Chang EY; Hammerberg C; Fisher G; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD
    Arch Dermatol; 1992 Nov; 128(11):1479-85. PubMed ID: 1359841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive effect of β, β-dimethylacryloyl alkannin on activated dendritic cells in an imiquimod-induced psoriasis mouse model.
    Wang Y; Zhao J; Zhang L; Di T; Liu X; Lin Y; Zeng Z; Li P
    Int J Clin Exp Pathol; 2015; 8(6):6665-73. PubMed ID: 26261548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable synthetic cytokine converter cells with AND-gate logic treat experimental psoriasis.
    Schukur L; Geering B; Charpin-El Hamri G; Fussenegger M
    Sci Transl Med; 2015 Dec; 7(318):318ra201. PubMed ID: 26676608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mometasone furoate decreases adhesion molecule expression in psoriasis.
    Berti E; Cerri A; Marzano AV; Richelda R; Bianchi B; Caputo R
    Eur J Dermatol; 1998 Sep; 8(6):421-6. PubMed ID: 9729054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural findings and tumor necrosis factor-alpha and intercellular adhesion molecule-1 expression in psoriasis patients before and after oral cyclosporin A therapy.
    Eşrefoğlu M; Gül M; Seyhan M
    Ultrastruct Pathol; 2006; 30(1):95-102. PubMed ID: 16517475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
    Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
    J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of cyclosporine A on Langerhans cells and regulatory T-cell populations in severe psoriasis: an immunohistochemical and flow cytometric analysis.
    Horrocks C; Duncan JI; Sewell HF; Ormerod AD; Thomson AW
    J Autoimmun; 1990 Oct; 3(5):559-70. PubMed ID: 2252524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytokines and their receptors by psoriatic fibroblasts. II. decreased TNF receptor expression.
    Debets R; Hegmans JP; Buurman WA; Benner R; Prens EP
    Cytokine; 1996 Jan; 8(1):80-8. PubMed ID: 8742070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of skin Th17 transcriptional profiles in psoriatic patients under adalimumab biotherapy.
    Buffiere-Morgado A; Couderc E; Delwail A; Favot L; Jegou JF; Solau E; Guillet G; Lecron JC; Morel F
    Eur J Dermatol; 2017 Dec; 27(6):579-589. PubMed ID: 29171393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings.
    Asadullah K; Friedrich M; Hanneken S; Rohrbach C; Audring H; Vergopoulos A; Ebeling M; Döcke WD; Volk HD; Sterry W
    J Invest Dermatol; 2001 May; 116(5):721-7. PubMed ID: 11348460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic Changes in Resident and Infiltrating Epidermal Dendritic Cells in Active and Resolved Psoriasis.
    Martini E; Wikén M; Cheuk S; Gallais Sérézal I; Baharom F; Ståhle M; Smed-Sörensen A; Eidsmo L
    J Invest Dermatol; 2017 Apr; 137(4):865-873. PubMed ID: 28011143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in cytokine secretion from mesenchymal stem cells in psoriatic skin lesions.
    Liu R; Yang Y; Yan X; Zhang K
    Eur J Dermatol; 2013; 23(5):600-7. PubMed ID: 24135516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol).
    Fukuoka M; Ogino Y; Sato H; Ohta T; Komoriya K; Nishioka K; Katayama I
    Br J Dermatol; 1998 Jan; 138(1):63-70. PubMed ID: 9536224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy.
    Vallat VP; Gilleaudeau P; Battat L; Wolfe J; Nabeya R; Heftler N; Hodak E; Gottlieb AB; Krueger JG
    J Exp Med; 1994 Jul; 180(1):283-96. PubMed ID: 7516410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis.
    Sofen H; Smith S; Matheson RT; Leonardi CL; Calderon C; Brodmerkel C; Li K; Campbell K; Marciniak SJ; Wasfi Y; Wang Y; Szapary P; Krueger JG
    J Allergy Clin Immunol; 2014 Apr; 133(4):1032-40. PubMed ID: 24679469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.